Skip to Content
Translational Research Program (TRP)
Contact CIP
Show menu
Search this site
Last Updated: 02/06/19

Lymphoma SPOREs

There are two distinct subtypes of lymphoma — Hodgkin lymphoma (HL) and a diverse group of non-Hodgkin lymphomas (NHL). According to the Surveillance, Epidemiology and End Results (SEER) Program data, it is estimated that in 2018 there will be a total of 83,180 new cases of lymphoma in the U.S. Of these, 74,680 are expected to be NHL cases and 8,500 cases will be HL. A total of 19,910 people are expected to die of NHL in 2018, while 1,050 HL deaths are expected. The incidence of NHL doubled from 1975 to 2004 but has leveled off since then. The five-year survival rate for patients with NHL has increased from 45.8% in 1975 to 71.4% based on the SEER 2008-2014 data. HL had a five-year survival rate of 69.9% in 1975 and from 2008 — 2014 the survival rate reached 86.6 % due to improved therapies. Despite these favorable trends, lymphomas remain a serious medical problem affecting thousands of individuals.